4//SEC Filing
Rowland Thomas Andrew 4
Accession 0001507496-25-000007
CIK 0001023024other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 5:53 PM ET
Size
5.3 KB
Accession
0001507496-25-000007
Insider Transaction Report
Form 4
Rowland Thomas Andrew
SVP, HEAD - ESTABLISHED BRANDS
Transactions
- Sale
Common Stock
2025-08-12$85.71/sh−4,975$426,407→ 40,794 total
Footnotes (2)
- [F1]The shares were sold in multiple trades at prices ranging from $85.52 to $86.22. The price reported above reflects the weighted average sales price.
- [F2]Includes 304 shares of ANI Pharmaceuticals, Inc. Common Stock that were acquired under the ANI Pharmaceuticals, Inc. Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(d) and Rule 16b-3(c).
Documents
Issuer
ANI PHARMACEUTICALS INC
CIK 0001023024
Entity typeother
Related Parties
1- filerCIK 0001507496
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 5:53 PM ET
- Size
- 5.3 KB